FDA Exempted Federal Drug Testing Systems From Review
The rule change eases the path for manufacturers of federal workplace drug testing technology.
Updated on Oct. 7, 2026 in Substance Abuse
Live Poll
Do you support the transition to oral fluid drug testing for federally regulated commercial drivers?
The FDA has finalized an order removing the 510(k) premarket notification requirement for 14 categories of clinical toxicology test systems. This change is intended to reduce regulatory burdens for systems used in federal drug testing programs.
Why it matters
By eliminating costly 510(k) submission requirements, the FDA aims to streamline the availability of testing technology while maintaining oversight through established certification processes. This could impact how quickly new diagnostic tools enter the federal workforce testing environment.
The FDA finalized this exemption for 14 categories of clinical toxicology test systems following feedback from approximately 70 commenters. While these systems no longer require 510(k) notification, they still must meet Department of Health and Human Services certification standards.
The players
Food and Drug Administration
The federal agency responsible for regulating medical devices and diagnostic test systems.
Department of Health and Human Services
The cabinet-level department that oversees clinical laboratory certifications and public health standards.
Department of Transportation
The federal department that sets workplace safety and drug testing regulations for regulated industries.
The details
Manufacturers currently must submit their toxicology test systems to the Department of Health and Human Services for certification to ensure accuracy when processing specimens. Under current Department of Transportation regulations, employers must use two separate HHS-certified laboratories to perform primary and split specimen testing for oral fluid results. This regulatory shift simplifies the manufacturing side without removing the requirement for labs to process samples under federal supervision.
Timeline
In 2023, the Department of Transportation authorized oral fluid testing as a workplace alternative.
The FDA proposed this exemption change in May 2026.
The FDA finalized the order on October 6, 2026.
Health Landscape
This development marks a shift in the regulatory path for diagnostic tools used in the federal drug testing sector. It aligns with the Department of Transportation oral fluid testing regulations by removing barriers for manufacturers seeking to provide approved testing systems.
This change affects the systems used for mandatory federal drug testing, though urine remains the only currently available method for DOT-regulated employees. If you are subject to federal workplace screening, discuss any questions about testing methods with your company's human resources or occupational health department.
The takeaway
The FDA has simplified the pathway for bringing new federal drug testing technology to market by removing specific notification requirements. Federal employers and employees should continue to monitor updates from the Department of Transportation regarding the implementation of new testing methods.
What happens next
The Department of Transportation will publish a Federal Register notice to initiate an 18-month transition period for observed collections.
Further reading
For broader context on current screening protocols, see the Substance Abuse section.
Live Poll
Do you support the transition to oral fluid drug testing for federally regulated commercial drivers?
